JJ

Joshy John

Active Director Managing Director DIN 06736076
DIN 06736076 First appointment Nov 2013 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2013
Shareholding value •••• Premium profile

About Joshy John

Data last updated:

Joshy John is a Managing Director at Chemwel Pharma Limited (since 2013). The company operates in Trading. Chemwel Pharma Limited reported revenue of ₹59.6 Lakh (FY 2025).

DIN 06736076
Primary Designation Managing Director
Industry Trading
First Appointment 22 Nov 2013
Oldest Company Age 28 yrs
Largest company Chemwel Pharma Limited · ₹59.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Chemwel Pharma Limited U24231KL1998PLC012114
Managing Director22 Nov 20131998₹59.6 Lakh (FY 2025)Active

Board colleagues of Joshy John

Directorship timeline

Open interactive timeline →
Chemwel Pharma Limited
Premium access

Shareholding and investment profile for Joshy John

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Joshy John

Joshy John currently holds 1 directorship: Chemwel Pharma Limited (Managing Director, since 22 Nov 2013, revenue ₹59.6 Lakh (FY 2025)).

Joshy John was first appointed on 22 Nov 2013 as Managing Director at Chemwel Pharma Limited.

The current boards of Joshy John's companies include Ratheesh Menon Pushpavenibalakrishna (Chemwel Pharma Limited), Soney Swamini Raveendran (Chemwel Pharma Limited), Sreekanth Raveendran (Chemwel Pharma Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available